510(k) Report

510(k) · Cleared

Cleared

Virazyme Influenza ID Test for Influenza Types a and B Viruses

K971494510(k) TraditionalCleared Sep 10, 1997139-day reviewClass I21 CFR 866.3330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Zymetx, Inc. · GNX Antigens, Cf (Including Cf Control), Influenza Virus A, B, C

Cleared on Sep 10, 1997 after a 139-day review. The FDA summary names no predicate by number.

Decided
Sep 10, 1997
Review
139 days
Class
Class I
Product code
GNX
Recalls
None
Predicates
0

The FDA summary names no predicate by number.

FIG. 1 — Lineage of K971494Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GNX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GNX devices

GNX Antigens, Cf (Including Cf Control), Influenza Virus A, B, C: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GNX

6in 2013

2012: 12013: 6
2007high 6 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GNX

27in 2013

2013: 27 days median
2007high 27 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GNX

1in 2012

2007: 42008: 12012: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GNX

93in 2025

2010: 12011: 22012: 42014: 32015: 32017: 12018: 22021: 362022: 322023: 612024: 32025: 93
2007high 93 (2025) · low 0 (2007)2025

MAUDE reports naming product code GNX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—40
20080—10
20090—00
20100—01
20110—02
20121—14
201362700
20140—03
20150—03
20160—00
20170—01
20180—02
20190—00
20200—00
20210—036
20220—032
20230—061
20240—03
20250—093
20260—0—

What is it indicated for?

The ViraZyme® Influenza ID test is a direct specimen test indicated for use in the qualitative detection of both influenza types A and B virus from throat swab specimens. The ViraZyme® Influenza ID test may be used when a patient is suspected of having symptoms of an influenza-like illness. These symptoms can include, but are not limited to the following: fever of 38.5°C, sore throat, headache, myalgia, rhinitis, vomiting, chills, malaise, and cough. A…

Read the full statement (119 words)

The ViraZyme® Influenza ID test is a direct specimen test indicated for use in the qualitative detection of both influenza types A and B virus from throat swab specimens. The ViraZyme® Influenza ID test may be used when a patient is suspected of having symptoms of an influenza-like illness. These symptoms can include, but are not limited to the following: fever of 38.5°C, sore throat, headache, myalgia, rhinitis, vomiting, chills, malaise, and cough. A positive ViraZyme® result would indicate the presence of influenza type A or B virus. A negative result is considered presumptive and should be confirmed by culture. The ViraZyme® Influenza ID test does not detect influenza C, and is indicated for in Vitro Diagnostic Use only.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971494: Virazyme Influenza ID Test for Influenza Types a and B Viruses.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K971494

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026